These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 28944281)

  • 21. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Doerfler W
    Virus Res; 2021 Sep; 302():198466. PubMed ID: 34087261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral Vector Production: Adenovirus.
    Kim JW; Morshed RA; Kane JR; Auffinger B; Qiao J; Lesniak MS
    Methods Mol Biol; 2016; 1382():115-30. PubMed ID: 26611583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy.
    Gao J; Zhang W; Ehrhardt A
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32370135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral vectors for gene therapy.
    Robbins PD; Ghivizzani SC
    Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoviral vectors for gene transfer and therapy.
    Volpers C; Kochanek S
    J Gene Med; 2004 Feb; 6 Suppl 1():S164-71. PubMed ID: 14978759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Adenoviruses in Cancer Therapy.
    Tseha ST
    Front Oncol; 2022; 12():772659. PubMed ID: 35756634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
    Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
    Elife; 2021 Oct; 10():. PubMed ID: 34664552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus as an integrating vector.
    Mitani K; Kubo S
    Curr Gene Ther; 2002 May; 2(2):135-44. PubMed ID: 12109211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral vector-based gene therapies in the clinic.
    Zhao Z; Anselmo AC; Mitragotri S
    Bioeng Transl Med; 2022 Jan; 7(1):e10258. PubMed ID: 35079633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and application of adenoviral vectors.
    Zhang H; Wang H; An Y; Chen Z
    Mol Ther Nucleic Acids; 2023 Dec; 34():102027. PubMed ID: 37808925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.
    Watanabe M; Nishikawaji Y; Kawakami H; Kosai KI
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in helper-dependent adenoviral vector research.
    Segura MM; Alba R; Bosch A; Chillón M
    Curr Gene Ther; 2008 Aug; 8(4):222-35. PubMed ID: 18691018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development.
    Luo S; Zhang P; Ma X; Wang Q; Lu J; Liu B; Zhao W; Allain JP; Li C; Li T
    Virus Res; 2019 Jul; 268():1-10. PubMed ID: 31108113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Therapy for Regenerative Medicine.
    Hosseinkhani H; Domb AJ; Sharifzadeh G; Nahum V
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy.
    Liu J; Seol DW
    BMB Rep; 2020 Nov; 53(11):565-575. PubMed ID: 32958121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized adenovirus gene delivery using antiviral IgG complexation.
    Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
    Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors.
    Schneider DB; Sassani AB; Vassalli G; Driscoll RM; Dichek DA
    J Vasc Surg; 1999 Mar; 29(3):543-50. PubMed ID: 10069919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
    van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
    J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral vectors for vascular gene therapy.
    Fischer L; Preis M; Weisz A; Koren B; Lewis BS; Flugelman MY
    Exp Clin Cardiol; 2002; 7(2-3):106-12. PubMed ID: 19649233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.